¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-07
±³À°ÀÏÀÚ : 2023-04-07
±³À°Àå¼Ò : ¿©¼ö º£³×Ä¡¾Æ È£ÅÚ ÄÁº¥¼Ç·ë

±³À°ÁÖÁ¦ : 2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ(¸íĪº¯°æ 22.9.19 ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ)
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-501-2988  

À̸ÞÀÏ : kates1996@naver.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 8 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í Æò»ýȸ¿ø : 10¸¸¿ø,12¸¸¿ø(ÇöÀå)Á¤È¸¿ø : 10¸¸¿ø, 12¸¸¿ø(ÇöÀå)Àü°øÀÇ : 7¸¸¿ø, 9¸¸¿ø(ÇöÀå) °£È£»ç : 5¸¸¿ø, 7¸¸¿ø(ÇöÀå)ºñȸ¿ø : 13¸¸¿ø, 15¸¸¿ø(ÇöÀå)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 13:00~13:30 1) Guidelines for the management of parathyroid disease ±è¼öÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 13:30~14:00 2) Various surgical treatment options for parathyroid disease ¹Ú´Ù¿ø(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 14:00~14:30 3) Follow up of parathyroid disease patients À̽ÃÈÆ(°¡ÃµÀÇ´ë ³»ºÐºñ´ë»ç³»°ú)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 14:30~15:00 1) Guidelines for adrenalectomy ±è±¤¼ø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 15:00~15:30 2) HALS(hand assisted laparoscopic surgery) adrenalectomy, searching for indication Á¶Àç¿ø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 15:30~16:00 3) AVS(adrenal venus sampling)ÀÇ À¯¿ë¼º ÀÌÃÊ·Ï(¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 04-07 16:00~16:20 Coffee Break ()

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 16:20~16:40 1) Clinical application of computer aided diagnosis in thyroid imaging °ûÁø¿µ(¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 16:40~17:00 2) Digital pathology Á¤Âù±Ç(°¡Å縯ÀÇ´ë º´¸®°ú)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 17:00~17:20 3) AI in paper work °­»óÈñ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-07 ÄÁº¥¼Ç·ë 17:20~17:40 4) Medical metaverse ¹Ú»óÁØ(¸ÞµðÄþÆÀÌÇÇ)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 13:00~13:10 OP-1-1. A multicenter, randomized controlled study of health-related quality of life by TSH suppression levels in thyroid lobectomy patients: An interim analysis of the master study ÀÌÀÚ°æ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 13:10~13:20 OP-1-2. Randomized clinical trial of prophylactic central neck dissection in 2000 PTC patients with clinically negative nodal disease: An interim analysis a single institution ¹é±³¸²(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 13:20~13:30 OP-1-3. Risk factor in re-recurrence PTC after initial total thyroidectomy ¹Ú»óÃá(Àü³²ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 13:30~13:40 OP-1-4. Determining surgery extent in unilateral papillary thyroid carcinoma based on intraoperative pathologic evaluation of the lymph node number and size ¹èÇý¸²(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 13:40~13:50 OP-1-5. The recurrence rate of isthmectomy in papillary thyroid carcinoma patients Á¤ÇѼÖ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 13:50~14:00 OP-1-6. Lymph node ratio predicts recurrence in papillary thyroid carcinoma with low lymph node yield ¾È¼ÖÁö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 14:00~14:10 OP-1-7. Comparision between s according to subtypes in papillary thyroid cancer ÀÌÁؼº(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 14:10~14:20 OP-1-8. Retropharyngeal node metastasis papillary thyroid carcinoma °­¼®¹Î(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 14:20~14:30 OP-1-9. Clinical significance of tumor size in gross extrathyroidal extension to strap muscles in differentiated thyroid carcinoma ¹ÚÁؼ±(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 14:30~14:40 OP-2-1. Robotic versus endoscopic transoral thyroidectomy in papillary thyroid cancer: A comparative analysis of surgical outcomes in 240 consecutive patients ÀÌÁØÈ£(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 14:40~14:50 OP-2-2. First experience of single port robotic areolar approach thyroidectomy (SPRA) ÀÌÁø¿í(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 14:50~15:00 OP-2-3. Clinical application of pectoralis nerve block II for flap dissection-related pain control after robotic transaxillary thyroidectomy: Preliminary results of a randomized controlled trial ±è±¤¼ø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 15:00~15:10 OP-2-4. Transoral endoscopic thyroidectomy vestibular approach(TOETVA), does this procedure increase the risk of surgical site infection? Àü¿µ»ê(´ë±¸±¸º´¿ø)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 15:10~15:20 OP-2-5. One-step single-port transaxillary robotic thyroidectomy with gas-insufflation À念¿ì(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 15:20~15:30 OP-2-6. Early muscular remodeling in patient with thyroid cancer after transaxillary robot-assisted surgery À±ÇõÁØ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 15:30~15:40 OP-2-7. Reduced-port robotic transperitoneal adrenalectomy(RPRTPA): The initial experience ±è¿ë¿±(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 15:40~15:50 OP-2-8. Analysis of risk factors to predict poor prognosis in oncocytic adrenocortical neoplasm(uncertain malignancy) patients ±èº´Ã¢(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 15:50~16:00 OP-2-9. Factors affecting steroid istration date after adrenalectomy with Cushing À̵¿±Ù(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 04-07 16:00~16:20 Coffee Break ()

±³À°½Ã°£ 04-07 Æ佺ŸȦ 16:20~16:45 ÀÏÂ÷¼º °í¾Ëµµ½ºÅ×·ÐÁõ ȯÀÚÀÇ Ä¡·á¹ÝÀÀÀ» ¿¹ÃøÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ Á¶Àç¿ø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 16:45~17:05 WHO grading system¿¡ µû¸¥ °©»ó¼± ¼öÁú¾ÏÀÇ ¿¹ÈÄ ¹× º´¸®ÇÐÀû ºÐ¼® : ´Ù±â°ü¿¬±¸ ÀÌÃÊ·Ï(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 17:05~17:25 °©»ó¼±¾Ï¿¡¼­ IGF2BP3 º¯ÀÌÀÇ ºóµµ ¹× ¿¹ÈÄÀÎÀÚ·Î½á ¿ªÇÒ ÃÖÁØ¿µ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-07 Æ佺ŸȦ 17:25~17:50 Çмú»ó ¿¬±¸°á°ú º¸°í : °©»ó¼±¾Ï ¹ÙÀÌ¿À¸¶Ä¿ °³¹ßÀ» À§ÇÑ cell-free DNA À¯È¿¼º Ž»ö ȲÇö¿í(ÀÌÈ­ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѾȰúÇÐȸ Á¦129ȸ Çмú´ëȸ(1ÀÏÂ÷) : 2023-04-07
´ÙÀ½±Û ´ëÇÑ°©»ó¼±¿µ»óÀÇÇÐȸ Á¦13Â÷ Çмú´ëȸ,2023 : 2023-04-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 920 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,040 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 850 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 680 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 769 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 991 2018-08-22
489 Àü³² Á¦257Â÷ ´ëÇѳ»°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Çмú´ëȸ : 2018-09-06 0 573 2018-08-22
488 °æ³² ´ëÇÑÇǺΰúÇÐȸ º£Ã¼Æ®º´ÀÇ ÃÖ½ÅÁö°ß¿¡ °üÇÏ¿© : 2018-09-06 0 717 2018-08-22
487 Ãæ³² °Ç¾ç´ëÇб³º´¿ø ´ëÇÑÇǺΰúÇÐȸ ÃæûÁöºÎÇÐȸ : 2018-09-06 0 897 2018-08-22
486 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦234Â÷ °æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 740 2018-08-22
485 °æ±â °¡Å縯´ëÇб³ ºÎõ¼º¸ðº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 3Â÷ ÀÎõ.°æ±âÁöȸ Áý´ãȸ : 2018-09-06 2 1,464 2018-08-22
484 °æ³² ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018³âµµ 3Â÷ ºÎ»ê¿ï»ê°æ³² ÈäºÎ¿Ü°ú Áý´ãȸ ¹× °­¿¬ : 2018-09-06 0 695 2018-08-22
483 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 529 2018-08-22
482 ºÎ»ê ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ¼­±¸ÀÇ»çȸ 9¿ù Çмúȸ : 2018-09-05 0 635 2018-08-22
481 ´ë±¸ 2018³â ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ 9¿ù Áý´ãȸ : 2018-09-05 0 476 2018-08-22
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷